Metabolism and Pharmacokinetic Drug–Drug Interaction Profile of Vericiguat, A Soluble Guanylate Cyclase Stimulator: Results From Preclinical and Phase I Healthy Volunteer Studies
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1179-1926
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Metabolism and Pharmacokinetic Drug–Drug Interaction Profile of Vericiguat, A Soluble Guanylate Cyclase Stimulator: Results From Preclinical and Phase I Healthy Volunteer Studies ; day:26 ; month:5 ; year:2020 ; pages:1-12
Clinical pharmacokinetics ; (26.5.2020), 1-12
- Creator
-
Boettcher, Michael
Gerisch, Michael
Lobmeyer, Maximilian
Besche, Nina
Thomas, Dirk
Gerrits, Mireille
Lemmen, Julia
Mueck, Wolfgang
Radtke, Martin
Becker, Corina
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s40262-020-00895-x
- URN
-
urn:nbn:de:101:1-2020073019352245537644
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:55 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Boettcher, Michael
- Gerisch, Michael
- Lobmeyer, Maximilian
- Besche, Nina
- Thomas, Dirk
- Gerrits, Mireille
- Lemmen, Julia
- Mueck, Wolfgang
- Radtke, Martin
- Becker, Corina
- SpringerLink (Online service)
Other Objects (12)
Evaluation of Safety and Clinically Relevant Drug–Drug Interactions with Tucatinib in Healthy Volunteers
A Review of Daclatasvir Drug–Drug Interactions
Drug–Drug Interactions with Direct Oral Anticoagulants
Extracting drug-drug interactions from biomedical texts
Investigation of drug–drug interactions and pain—From volunteer studies to randomized controlled trials in patients with chronic pain
Lurasidone drug-drug interaction studies: a comprehensive review
Delta-9-Tetrahydrocannabinol and Cannabidiol Drug-Drug Interactions
Pharmacovigilance of Drug–Drug Interactions with Nirmatrelvir/Ritonavir
Case report: Medical cannabis—warfarin drug-drug interaction
DPDDI: a deep predictor for drug-drug interactions
Evaluating drug-drug interaction information in NDF-RT and DrugBank
A Minimal Information Model for Potential Drug-Drug Interactions
Evaluation of Safety and Clinically Relevant Drug–Drug Interactions with Tucatinib in Healthy Volunteers
A Review of Daclatasvir Drug–Drug Interactions
Drug–Drug Interactions with Direct Oral Anticoagulants
Extracting drug-drug interactions from biomedical texts
Investigation of drug–drug interactions and pain—From volunteer studies to randomized controlled trials in patients with chronic pain
Lurasidone drug-drug interaction studies: a comprehensive review
Delta-9-Tetrahydrocannabinol and Cannabidiol Drug-Drug Interactions
Pharmacovigilance of Drug–Drug Interactions with Nirmatrelvir/Ritonavir
Case report: Medical cannabis—warfarin drug-drug interaction
DPDDI: a deep predictor for drug-drug interactions
Evaluating drug-drug interaction information in NDF-RT and DrugBank
A Minimal Information Model for Potential Drug-Drug Interactions
Evaluation of Safety and Clinically Relevant Drug–Drug Interactions with Tucatinib in Healthy Volunteers
A Review of Daclatasvir Drug–Drug Interactions
Drug–Drug Interactions with Direct Oral Anticoagulants
Extracting drug-drug interactions from biomedical texts
Investigation of drug–drug interactions and pain—From volunteer studies to randomized controlled trials in patients with chronic pain
Lurasidone drug-drug interaction studies: a comprehensive review
Delta-9-Tetrahydrocannabinol and Cannabidiol Drug-Drug Interactions
Pharmacovigilance of Drug–Drug Interactions with Nirmatrelvir/Ritonavir
Case report: Medical cannabis—warfarin drug-drug interaction
DPDDI: a deep predictor for drug-drug interactions
Evaluating drug-drug interaction information in NDF-RT and DrugBank